XWMJXDBAQSQLFZ-UHFFFAOYSA-N
C34H36F3N7O4S — CID 59663755
Data last refreshed: (MolForge compound catalog, from PubChem)
About XWMJXDBAQSQLFZ-UHFFFAOYSA-N
XWMJXDBAQSQLFZ-UHFFFAOYSA-N (PubChem CID 59663755) has the molecular formula C34H36F3N7O4S and a molecular weight of 695.77 g/mol. Its IUPAC name is 1-[2-[2-(dimethylamino)ethoxy]-3-(trifluoromethyl)phenyl]-N-[4-(13,13-dioxo-13λ6-thia-2,4,8,12,19-pentazatricyclo[12.3.1.13,7]nonadeca-1(18),3,5,7(19),14,16-hexaen-6-yl)phenyl]cyclopropane-1-carboxamide.
Molecular Properties
| Compound Name | XWMJXDBAQSQLFZ-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 59663755 |
| Molecular Formula | C34H36F3N7O4S |
| Molecular Weight | 695.77 g/mol |
| Exact Mass | 695.25 |
| IUPAC Name | 1-[2-[2-(dimethylamino)ethoxy]-3-(trifluoromethyl)phenyl]-N-[4-(13,13-dioxo-13λ6-thia-2,4,8,12,19-pentazatricyclo[12.3.1.13,7]nonadeca-1(18),3,5,7(19),14,16-hexaen-6-yl)phenyl]cyclopropane-1-carboxamide |
| SMILES | CN(C)CCOc1c(C(F)(F)F)cccc1C1(C(=O)Nc2ccc(-c3cnc4nc3NCCCNS(=O)(=O)c3cccc(c3)N4)cc2)CC1 |
| InChI | InChI=1S/C34H36F3N7O4S/c1-44(2)18-19-48-29-27(8-4-9-28(29)34(35,36)37)33(14-15-33)31(45)41-23-12-10-22(11-13-23)26-21-39-32-42-24-6-3-7-25(20-24)49(46,47)40-17-5-16-38-30(26)43-32/h3-4,6-13,20-21,40H,5,14-19H2,1-2H3,(H,41,45)(H2,38,39,42,43) |
| InChIKey | XWMJXDBAQSQLFZ-UHFFFAOYSA-N |
| XLogP | 5.61 |
| TPSA | 137.58 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 49 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 695.77 |
| LogP ≤ 5 | 5.61 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 59663755 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.